2 terminated, 1 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
| Phase 2 | 1 | Completed 1 |
Follow TAK-071: new trials by email Literature Review of TAK-071 trials Research Report on TAK-071
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of TAK-071 in People With Parkinson Disease TAK-071, Placebo - Parkinson Disease, Healthy Participants | Phase 2 | Completed | Takeda | 64 | 2020-10-21 | 2024-05-14 |
| TAK-071 Scopolamine-Induced Cognitive Impairment Study Scopolamine, TAK-071, Donepezil - Healthy Volunteers | Phase 1 | Terminated | Takeda | 18 | 2016-11-21 | 2019-06-14 |
| Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy Participants TAK-071, Donepezil, TAK-071 Placebo - Alzheimer Disease, Healthy Volunteers | Phase 1 | Terminated | Takeda | 179 | 2016-05-05 | 2019-06-10 |
Alzheimer Disease (1) · Parkinson Disease (1)
Takeda (3)
United States (3)